SMAD4 Y353C promotes the progression of PDAC

BACKGROUND: SMAD4 is frequently inactivated and associated with a poor prognosis in pancreatic ductal adenocarcinoma (PDAC). Abnormal SMAD4 expression also plays an important role in the malignant progression of PDAC. METHODS: We investigated SMAD4 status in PDAC by immunohistochemical methods to ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zusen, Li, Yongxing, Zhan, Shixiong, Zhang, Lu, Zhang, Shun, Tang, Qian, Li, Miaomiao, Tan, Zhen, Liu, Shiguo, Xing, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829834/
https://www.ncbi.nlm.nih.gov/pubmed/31684910
http://dx.doi.org/10.1186/s12885-019-6251-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829834/
https://www.ncbi.nlm.nih.gov/pubmed/31684910
http://dx.doi.org/10.1186/s12885-019-6251-7

Ejemplares similares